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ABSTRACT
We report the case of a 78-year-old male patient who presented with dysuria and lower urinary tract 
symptoms (LUTS). After routine blood and urine analysis, the patient underwent ultrasonography 
which revealed a hypertrophied and inhomogenous prostate extending to the bladder neck. Open 
biopsy from the bladder neck was performed. The histopathological findings were found to be 
consistent with prostatic duct adenocarcinoma with endometrioid features. 
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INTRODUCTION                                                    
Prostatic duct adenocarcinoma with 
endometrioid features (PDAE) is a very 
rare tumor which is thought to arise from 
the prostatic utricle (a Müllerian rem-
nant anologous to the female uterus and 
vagina)1. Lower urinary tract symptoms 
(LUTS) are the most common presentation.
CASE REPORT                                      
A 78-year-old man was admitted to our 
clinic with dysuria and LUTS. Routine 
physical examination and serum biochemistry 
were normal. Urinalysis revealed proteinuria 
and hematuria. Total prostate specific antigen 
(PSA) was 15.29 ng/ml while free PSA was 
6.47 ng/ml. Ultrasonography demonstrated 
an inhomogenous prostate measuring 40 x 
47 x 59 mm with an irregular surface and 
prostatic tissue extending to the bladder neck. 
Open bladder neck biopsy was performed. 
Macroscopically, there were brownish 
tissue fragments weighing about 6 grams. 
Histological examination demonstrated 
closely packed glandular structures lined 
by pseudostratified, tall columnar cells with 
papillary projections and intraglandular 
bridging, consistent with PDAE (Fig 1).
DISCUSSION                                                             
PDAE has long been considered to ori-
ginate from the Müllerian remnant. Howe-
ver, Ro et al. have suggested that this entity 
should be accepted as an adenocarcinoma of 
prostatic duct origin2. Zaloudek et al. pointed 
out that the presence of strong acid phospha-
tase staining and multi-vacuolated, lysosome 
containing tumor cells strongly suggests a 
prostatic duct origin3. Therefore, the term 
‘ductal adenocarcinoma’ has been suggested. 
The histopathology of ductal adenocarci-
noma is generally characterized by a cribri-
form pattern with large slit-like lumina, tall 
columnar cells and papillary fronds with fi-
brovascular cores. The gland structures in 
these tumors are significantly larger than 
in common acinar carcinoma4. Since the 
term‘endometrial carcinoma arising from the 
prostatic utricle’ was initially coined, there 
has been growing evidence that the presence 
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Eade et al. reported sucessful clinical 
outcomes with EBR in a series of 6 patients, 
in which 5 were treated definitively and the 
sixth patient was treated for local recurrence 
after radical prostatectomy10. 
This case demonstrates the importance of 
thorough investigation of LUTS, where the 
differential diagnosis includes infection, stone 
disease or tumor, which may on occasion be a 
rare entity such as PDAE11. 
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of cribriform pattern in prostate cancers may 
indicate a proclivity to intraductal invasion4.
In contrast to malignant lesions, benign 
proliferative lesions of the prostate are 
characterized by the presence of basal cells. 
However, some cases of cribriform carcinoma 
comprising Gleason 3 and 4 histopathological 
grades have been demonstrated to have basal 
cells on immunohistochemistry4. Therefore, a 
cribriform carcinoma without basal cells may 
be interpreted as an invasive carcinoma with 
Gleason pattern 3 or 4, whereas it is generally 
termed high-grade prostatic intraepithelial 
neoplasia (HG-PIN) in the presence of basal 
cells4. The identification of basal cells is 
clinically important, and may help rule out 
infiltrating acinar prostatic adenocarcinoma5. 
PDAE has a patchy basal cell layer and 
immunohistochemically expresses PSA6. It is 
mostly equivalent to Gleason pattern 46.
There are few case reports of this entity 
in the literature. Hideto et al. reported a 58- 
year-old man with PDAE leading to symptoms 
of hematuria and bladder outlet obstruction1. 
Fukui et al. reported a 64-year-old man 
with the same tumor who underwent total 
cystoprostatectomy and urethrectomy7. This 
tumor has highly aggressive clinical behavior 
with high local recurrence rates4. The 5-year 
survival rate is 24% for adenocarcinomas that 
invade peripheral prostatic ducts8. Though 
surgery is the mainstay of treatment, external 
beam radiotherapy (EBR) has emerged as 
an important adjunctive modality. Androgen 
deprivation therapy may provide palliation9. 
Fig. 1: Photomicrograph showing prostatic duct adenocarci-
noma with endometrioid features (HE 50X).
